Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter S Hendricks

Showing results (51-60 of 145) with videos related to

Pageof 15
Sort By:
Therapeutic Advances in Psychopharmacology|December 5, 2022
Classic psychedelics, health behavior, and physical healthOtto Simonsson, Peter S Hendricks, Richard Chambers, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2021
Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past YearOtto Simonsson, Peter S Hendricks, Robin Carhart-Harris, et al.
JAMA Network Open|March 10, 2026
Psilocybin or Nicotine Patch for Smoking Cessation: A Pilot Randomized Clinical TrialMatthew W Johnson, Gideon P Naudé, Peter S Hendricks, et al.
Journal of Substance Abuse Treatment|June 12, 2021
Self-reported reductions in tobacco and nicotine use following medical cannabis initiation: Results from a cross-sectional survey of authorized medical cannabis patients in CanadaPhilippe Lucas, Zach Walsh, Peter S Hendricks, et al.
Journal of Affective Disorders|July 11, 2025
Naturalistic psychedelic use and changes in depressive symptomsOtto Simonsson, Peter S Hendricks, Caroline M Swords, et al.
Respiratory Care|April 20, 2022
The Influence of Mental Health and Respiratory Symptoms on the Association Between Chronic Lung Disease and E-Cigarette Use in Adults in the United StatesMohammed M Alqahtani, Gregory Pavela, Donald H Lein, et al.
Journal of Psychoactive Drugs|February 11, 2024
Psychedelic Microdosing among Young Adults from Southern CaliforniaAlyssa F Harlow, Peter S Hendricks, Adam M Leventhal, et al.
Frontiers in Psychology|July 21, 2023
Altered states of leadership: mindfulness meditation, psychedelic use, and leadership developmentOtto Simonsson, Cecilia U D Stenfors, Simon B Goldberg, et al.
Psychopharmacology|October 24, 2023
Psychedelic use and psychiatric risksOtto Simonsson, Simon B Goldberg, Richard Chambers, et al.
Journal of Psychopharmacology (Oxford, England)|March 7, 2022
Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide in healthy participants within a novel intervention paradigm: Qualitative results from a proof-of-concept studyPeter S Hendricks, Heith Copes, Neiloufar Family, et al.
Pageof 15

Showing results (51-60 of 145) with videos related to

Sort By:
Pageof 15
Therapeutic Advances in Psychopharmacology|December 5, 2022
Classic psychedelics, health behavior, and physical healthOtto Simonsson, Peter S Hendricks, Richard Chambers, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2021
Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past YearOtto Simonsson, Peter S Hendricks, Robin Carhart-Harris, et al.
JAMA Network Open|March 10, 2026
Psilocybin or Nicotine Patch for Smoking Cessation: A Pilot Randomized Clinical TrialMatthew W Johnson, Gideon P Naudé, Peter S Hendricks, et al.
Journal of Substance Abuse Treatment|June 12, 2021
Self-reported reductions in tobacco and nicotine use following medical cannabis initiation: Results from a cross-sectional survey of authorized medical cannabis patients in CanadaPhilippe Lucas, Zach Walsh, Peter S Hendricks, et al.
Journal of Affective Disorders|July 11, 2025
Naturalistic psychedelic use and changes in depressive symptomsOtto Simonsson, Peter S Hendricks, Caroline M Swords, et al.
Respiratory Care|April 20, 2022
The Influence of Mental Health and Respiratory Symptoms on the Association Between Chronic Lung Disease and E-Cigarette Use in Adults in the United StatesMohammed M Alqahtani, Gregory Pavela, Donald H Lein, et al.
Journal of Psychoactive Drugs|February 11, 2024
Psychedelic Microdosing among Young Adults from Southern CaliforniaAlyssa F Harlow, Peter S Hendricks, Adam M Leventhal, et al.
Frontiers in Psychology|July 21, 2023
Altered states of leadership: mindfulness meditation, psychedelic use, and leadership developmentOtto Simonsson, Cecilia U D Stenfors, Simon B Goldberg, et al.
Psychopharmacology|October 24, 2023
Psychedelic use and psychiatric risksOtto Simonsson, Simon B Goldberg, Richard Chambers, et al.
Journal of Psychopharmacology (Oxford, England)|March 7, 2022
Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide in healthy participants within a novel intervention paradigm: Qualitative results from a proof-of-concept studyPeter S Hendricks, Heith Copes, Neiloufar Family, et al.
Pageof 15